Abstract
High expression levels of cyclooxygenase 2 expression and infiltration by regulatory T cells (Tregs) are often associated with tumor progression. We have recently reported a prostaglandin E2 (PGE2)-dependent recruitment of Tregs to the tumor, suggesting that targeting specific PGE2 receptors may constitute a valuable approach to ablate the immunoediting that occurs along with disease progression.
Original language | English (US) |
---|---|
Article number | e23129 |
Journal | OncoImmunology |
Volume | 2 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2013 |
Keywords
- EP2
- EP4
- Immunosuppression
- Immunotherapy
- Mammary tumor
- Regulatory T cell
ASJC Scopus subject areas
- Oncology
- Immunology and Allergy
- Immunology